Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;13(9):e006910.
doi: 10.1161/CIRCHEARTFAILURE.120.006910. Epub 2020 Sep 8.

Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients

Affiliations

Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients

Ersilia M DeFilippis et al. Circ Heart Fail. 2020 Sep.

Abstract

Background: Advanced heart failure therapies such as left ventricular assist device (LVAD) implantation require intricate follow-up and complex care. We sought to explore the burden of psychosocial risk factors among patients with LVAD and their impact on postimplant outcomes using the Interagency Registry for Mechanically Assisted Circulatory Support.

Methods: Adult patients in the Interagency Registry for Mechanically Assisted Circulatory Support requiring durable LVAD between 2008 and 2017 were included. Individuals were determined to have psychosocial risk if they had one of the following: (1) limited social support; (2) limited cognition; (3) substance abuse (alcohol and drug); (4) severe psychiatric disease (including major depression and other major psychiatric diagnosis); and (5) repeated noncompliance. Univariate and multivariate Cox proportional hazard regression models were used to analyze predictors of survival and complications.

Results: A total of 15 403 continuous-flow LVAD recipients were included. A total of 3163 (20.5%) had one or more psychosocial risk factors. The most prevalent psychosocial risk factor was substance abuse in 1941 (12.6%) recipients. Patients with psychosocial risk factors were significantly younger at LVAD implant, less likely to be White, and less likely to be female compared with those without psychosocial risk, P<0.001 for all. Patients with psychosocial risk were significantly more likely to receive an LVAD as destination therapy, P<0.001. In adjusted models, patients with psychosocial risk were at increased hazards for device-related infection, gastrointestinal bleeding, pump thrombosis, and readmission and reduced hazards for cardiac transplantation (P<0.05 for all). There was no statistically significant difference in survival on pump support or stroke.

Conclusions: Psychosocial risk is an important component of patient selection for advanced heart failure therapies. Addressing these specific components may help improve access to advanced therapies and post-LVAD outcomes.

Keywords: compliance; heart failure; heart-assist devices; risk factors; social support.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. The Burden of Psychosocial Risk Factors in INTERMACS
This schematic highlights the five domains used to characterize psychosocial risk: social support, cognition, substance use, psychopathology, and non-compliance (Panel A). The respective frequency of various psychosocial risk factors in the INTERMACS database is also shown. In Panel B, a bar graph highlights that the majority of patients with psychosocial risk had only one of the five risk factors.
Figure 2.
Figure 2.. Psychosocial Risk Domains and Associated Outcomes
Network diagram is shown displaying associations between each domain of psychosocial risk to LVAD complications and outcomes
Figure 3.
Figure 3.. The Five Domains of Psychosocial Risk
This schematic further summarizes the five components of psychosocial risk evaluated in the current study. Connections were made between risk factors and outcomes if the adjusted hazard ratios were statistically significant. The multivariate model used was adjusted for age, gender, race, heart failure etiology, body surface area (BSA), year of implant, history of right ventricular assist device (RVAD) use, pump type (axial vs. centrifugal), INTERMACS profile, device strategy (destination therapy vs bridge to transplant or recovery), creatinine, bilirubin, and albumin levels.

Comment in

References

    1. Mehra MR, Goldstein DJ, Uriel N, Cleveland JC, Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, Itoh A, Dean D, Krishnamoorthy A, Cotts WG, Tatooles AJ, Jorde UP, Bruckner BA, Estep JD, Jeevanandam V, Sayer G, Horstmanshof D, Long JW, Gulati S, Skipper ER, O’Connell JB, Heatley G, Sood P, Naka Y, MOMENTUM 3 Investigators. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018;378:1386–1395. - PubMed
    1. Bui QM, Allen LA, LeMond L, Brambatti M, Adler E. Psychosocial Evaluation of Candidates for Heart Transplant and Ventricular Assist Devices: Beyond the Current Consensus. Circ: Heart Failure [Internet]. 2019. [cited 2019 Nov 14];12 Available from: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.119.006058 - DOI - PubMed
    1. Givertz MM. Cardiology patient pages: ventricular assist devices: important information for patients and families. Circulation. 2011;124:e305–311. - PubMed
    1. Petty M, Bauman L. Psychosocial issues in ventricular assist device implantation and management. J Thorac Dis. 2015;7:2181–2187. - PMC - PubMed
    1. Eshelman AK, Mason S, Nemeh H, Williams C. LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant. Heart Fail Rev. 2009;14:21–28. - PubMed

Publication types